ENTITY
Alnylam Pharmaceuticals

Alnylam Pharmaceuticals (ALNY US)

88
Analysis
Health Care • United States
Alnylam Pharmaceuticals Inc. is an early-stage therapeutics company. The Company is developing technology that can specifically and potently silence disease-causing genes.
more
bullish•Seagate
•11 Dec 2025 09:12

Nasdaq100 December 2025 Forecast (Final): 12 Changes

​STX, ALNY, WDC are the top forecasted addition. TTD, ON, LULU are the top forecasted deletions. FER can be a surprise addition displacing EBAY.

Share
bullish•Marvell Technology
•04 Dec 2025 06:22

Marvell Technology (MRVL US): Heroic Earnings Unlock S&P500 Eligibility

MRVL is labelled bullish for index rebalance but bearish in fundamentals following the fourth consecutive positive earnings and high price-to...

Share
bullish•CRH
•03 Dec 2025 19:11

Quiddity Leaderboard SP500/600 Dec25 Rebal: Last Minute Surprise in The Leading Names

SP500 rankings will be decided at today's open and announced on 5 December after the close. We see $100bn to trade across the SP500 complex. Kalshi...

Logo
587 Views
Share
bullish•Comfort Systems Usa
•03 Dec 2025 10:12

S&P500 December 2025 Final Forecast: FIX & CRH Leading the Pack

​CRH and FIX are top candidates for addition in December 2025, while PSTG and SOLS face reduced conviction. VRT has a higher chance of inclusion...

Share
bullish•CRH
•22 Nov 2025 22:08

[Quiddity Index] SP500/600 Dec25 Rebal: Two ADDs Two DELs and 3 Intra-Review Changes Likely Soon

SP500 could see two changes in Dec25. One has a lot to buy if chosen. There are also a few intra-review actions/changes scheduled for the near...

Logo
638 Views
Share
x